In summary, evidence from the literature suggests that UCP2 may act as a tumour suppressor during tumour initiation while it can have the opposite role as tumour promoter during progression, though exerting the same biochemical function at both stages [136,137]. This evidence concerns the gene UCP2 and neoplasm.